Franklin Resources, Inc. vs Heron Therapeutics Inc — how do they compare? Franklin Resources, Inc. trades at $33.24 (market cap $17.06B), while Heron Therapeutics Inc trades at $0.43 (market cap $78.91M). The key difference: Franklin Resources, Inc. is far larger — about 216.2× Heron Therapeutics Inc's market cap, and Franklin Resources, Inc. pays a 4.02% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BEN | HRTX | |
|---|---|---|
Market Cap | $17.06B | $78.91M |
Sector | Financials | Health |
52-Week High | $34.44 | $2.04 |
52-Week Low | $21.18 | $0.39 |
Enterprise Value | $28.88B | $176.81M |
Dividend Yield | 4.02% | — |
Trailing returns across standard periods
Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.
Read more on BEN →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →